Back
PIMCO Corporate & Income Opportunity Fund Vs. Revolution Medicines, Inc. Industry Stock Comparison
Sell
49
PTY
PIMCO Corporate & Income Opportunity Fund
Last Price:
$13.18
Seasonality Move:
-0.57%
Buy
64
RVMD
Revolution Medicines, Inc.
Last Price:
$113.97
Seasonality Move:
-1.63%
Sell
49
PIMCO Corporate & Income Opportunity Fund (PTY)
is a Sell
Is PIMCO Corporate & Income Opportunity Fund a Buy, Sell or Hold?
-
The current PIMCO Corporate & Income Opportunity Fund [PTY] share price is $13.16. The Score for PTY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
PTY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Revolution Medicines, Inc. (RVMD)
is a Buy
Is Revolution Medicines, Inc. a Buy, Sell or Hold?
-
The current Revolution Medicines, Inc. [RVMD] share price is $107.39. The Score for RVMD is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
RVMD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTY Stock Price Chart
What is PIMCO Corporate & Income Opportunity Fund's stock price today?
-
The PIMCO Corporate & Income Opportunity Fund share price today is $13.16The current trend is relatively stagnant and PTY is experiencing buying pressure, which is a positive indicator for future bullish movement.
RVMD Stock Price Chart
What is Revolution Medicines, Inc.'s stock price today?
-
The Revolution Medicines, Inc. share price today is $107.39Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RVMD is experiencing slight buying pressure.
PTY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 56.28 | Buy |
| Chaikin Money Flow: | 592211 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.86 - 13.14) | Buy |
| Bollinger Bands (100): | (13.14 - 14.3) | Sell |
RVMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.48 | Buy |
| Relative Strength Index (14 RSI): | 88.38 | Buy |
| Chaikin Money Flow: | 5950544 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.87 - 88.29) | Buy |
| Bollinger Bands (100): | (42.5 - 75.96) | Buy |
PTY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.03 | Buy |
| 20-day SMA: | 12.96 | Buy |
| 50-day SMA: | 13.21 | Sell |
| 200-day SMA: | 13.74 | Sell |
| 8-day EMA: | 13.06 | Buy |
| 20-day EMA: | 13.03 | Buy |
| 50-day EMA: | 13.24 | Sell |
| 200-day EMA: | 13.74 | Sell |
RVMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.89 | Buy |
| 20-day SMA: | 81.66 | Buy |
| 50-day SMA: | 73.85 | Buy |
| 200-day SMA: | 48.59 | Buy |
| 8-day EMA: | 89.67 | Buy |
| 20-day EMA: | 83.17 | Buy |
| 50-day EMA: | 74.2 | Buy |
| 200-day EMA: | 54.94 | Buy |
PIMCO Corporate & Income Opportunity Fund Earnings Growth & PTY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Revolution Medicines, Inc. Earnings Growth & RVMD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.74 per share, and an increase next year of $0.59 per share.
PIMCO Corporate & Income Opportunity Fund Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Revolution Medicines, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||